Viewing Study NCT00612820


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-02-24 @ 2:52 PM
Study NCT ID: NCT00612820
Status: COMPLETED
Last Update Posted: 2016-11-03
First Post: 2008-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
Sponsor: GlaxoSmithKline
Organization: